BR100 Decreased By (-0.98%)
BR30 Decreased By (-0.58%)
KSE100 Decreased By (-0.97%)
KSE30 Decreased By (-1.07%)
AGHA 7.70 Decreased By ▼ -0.11 (-1.41%)
BECO 5.16 Decreased By ▼ -0.05 (-0.96%)
BML 56.60 Decreased By ▼ -0.90 (-1.57%)
BOP 33.82 Decreased By ▼ -0.21 (-0.62%)
CNERGY 9.95 Decreased By ▼ -0.01 (-0.1%)
CSIL 5.30 Decreased By ▼ -0.01 (-0.19%)
FCCL 53.07 Decreased By ▼ -1.63 (-2.98%)
FFL 16.58 Decreased By ▼ -0.11 (-0.66%)
FNEL 1.22 Decreased By ▼ -0.01 (-0.81%)
KEL 7.27 Decreased By ▼ -0.13 (-1.76%)
KOSM 5.73 Decreased By ▼ -0.04 (-0.69%)
LOTCHEM 29.55 Increased By ▲ 0.23 (0.78%)
MLCF 92.90 Decreased By ▼ -1.46 (-1.55%)
NBP 202.00 Decreased By ▼ -1.05 (-0.52%)
NCPL 56.84 Decreased By ▼ -0.16 (-0.28%)
NPL 66.62 Decreased By ▼ -1.08 (-1.6%)
OGDC 318.98 Increased By ▲ 3.14 (0.99%)
PACE 10.55 Decreased By ▼ -0.09 (-0.85%)
PAEL 42.31 Decreased By ▼ -0.89 (-2.06%)
PIBTL 16.39 Decreased By ▼ -0.35 (-2.09%)
PPL 218.50 Decreased By ▼ -1.28 (-0.58%)
PRL 51.20 Increased By ▲ 2.01 (4.09%)
PTC 70.00 Decreased By ▼ -0.53 (-0.75%)
SSGC 26.96 Decreased By ▼ -1.29 (-4.57%)
TBL 9.75 Decreased By ▼ -0.11 (-1.12%)
TELE 8.68 Decreased By ▼ -0.11 (-1.25%)
TPL 17.99 Decreased By ▼ -0.25 (-1.37%)
TPLP 13.44 Increased By ▲ 0.17 (1.28%)
TREET 22.55 Decreased By ▼ -0.17 (-0.75%)
TRG 59.48 Decreased By ▼ -0.66 (-1.1%)

KARACHI: Bank Alfalah has partnered with Cancer Foundation Hospital to provide life-saving treatment to women battling breast cancer.

As part of this collaboration, Bank Alfalah and Roche Pakistan have contributed a total of PKR 10.75 million towards medication expenses and free-of-cost treatment for five breast cancer patients, ensuring they receive comprehensive treatment.

Mehreen Ahmed, Group Head of Retail Banking, said that Bank Alfalah believes in going beyond business operations to address critical societal issues. “Breast cancer is a major health challenge, and through our partnership with Cancer Foundation Hospital, we aim to provide tangible support to women battling cancer.”

Copyright Business Recorder, 2024

Comments

Comments are closed for this article.